Molnupiravir listed on PBS

Commencing 1 March 2022 Lagevrio® (molnupiravir) has been listed on the Pharmaceutical Benefits Scheme (PBS) Section 85 program as an Authority Required (Streamlined) benefit for patients with mild-moderate COVID 19 who have a high risk for developing severe disease, reducing the need for admission to hospital.

Read more

COVID-19 Vaccine Exemptions – 18 February Update

COVID-19 vaccines have been demonstrated to be safe and effective and are recommended for all people aged 5 years and over.

There are very few situations where a COVID-19 vaccine may not be safe to use.

Medical exemptions can only be granted if there are no suitable alternative COVID-19 vaccines available.

For this reason, permanent medical exemptions to COVID-19 vaccination will be rarely required.

The Updated factsheet which outlines the circumstances in which your doctor can grant a medical exemption for receiving a COVID-19 vaccine is here.

PCIG Update – 2 March 2022

Department of Health – Primary Health Care COVID-19 Response Teleconference 2 March 2022 – Meeting notes from Dr Maria Boulton

The Primary Care Implementation Group (PCIG) is an online meeting that includes most primary healthcare peak bodies. It is convened weekly by the Department of Health as part of the COVID-19 response. Dr Maria Boulton attends on behalf of the AGPA.

Read more

Updated ATAGI recommendations on the use of a booster dose of COVID-19 vaccine

The Australian Technical Advisory Group on Immunisation (ATAGI) have updated their recommendations on the use of booster doses of COVID-19 vaccine.

Read more

PCIG Notes 8 December

Department of Health – Primary Health Care COVID-19 Response Teleconference 8 December  2021 – Meeting notes from Dr Maria Boulton

The Primary Care Implementation Group (PCIG) is an online meeting that includes most primary healthcare peak bodies. It is convened weekly by the Department of Health as part of the COVID-19 response. Dr Maria Boulton attends on behalf of the AGPA. Read more

GP COVID Vaccinations Exceed 20M

The latest vaccination data shows the  its importance of General Practice to  Australian Heathcare  having delivered  over 20M or approximately 50% of the 40M vaccination doses administered to date.

Read more

Survey Results – Most GPS will not participate in COVID in the Community – General Practice Care

The results of the AGPA survey on COVID  in the Community –  GP Care  indicates that most GPs consider the risks to their Practices and other patients to be too high and they are too busy with the regular roles of General Practice; so they not intending to participate in the program.

Read more

December ATAGI Statements Regarding COVID Vaccination Boosters

 

ATAGI have made a number of recent statements which are important for Practices participating in the  COVID vaccination program.

Read more

AGPA wins – Telehealth to be included in SWPE, DPA Regions Expanded.

 

Following submissions and lobbying via forums such as the PCIG and Senate inquiries two  of the issues on the AGPA agenda have had positive responses from the Commonwealth Government.

Read more